Gogoro Inc vs UnitedHealth Group Inc — how do they compare? Gogoro Inc trades at $2.89 (market cap $56.21M), while UnitedHealth Group Inc trades at $379.1 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 5923.5× Gogoro Inc's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Gogoro Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gogoro Inc for 14 Days and UnitedHealth Group Inc for 97 Days on average.
| GGR | UNH | |
|---|---|---|
Market Cap | $56.21M | $332.96B |
Volume | 14,026 | 7,273,749 |
Sector | Consumer Cyclical | Health |
52-Week High | $5.15 | $436.35 |
52-Week Low | $2.20 | $259.02 |
Typical Hold Time | 14 Days | 97 Days |
Enterprise Value | $342.65M | $374.82B |
Dividend Yield | — | 2.5% |
Signals from Pluang's Aura AI — not financial advice
GGR trades at $2.99, down 6.27% today, with a bullish technical signal from moving averages but negative profitability metrics including a -16.68% net income margin. Recent developments include new board appointments and a $61.8 million equity investment announced in October 2026. The company shows revenue growth from $281 million in 2025 to $286 million projected for 2026, though net losses persist.
The outlook remains cautious with 100% hold ratings from analysts. Investment appeal lies in the low P/S of 0.18 and EV/EBITDA of 6.38, but risks include sustained negative cash flow and high debt-to-asset ratio of 60%. Positive technical momentum contrasts with fundamental challenges in achieving profitability.
UnitedHealth Group (UNH) trades at $375.98, showing minor daily weakness but maintaining a bullish technical signal. The company reported strong Q2 2026 earnings, beating estimates, and reaffirmed its full-year outlook. Revenue growth remains robust, though net margins have compressed from prior years. Analyst sentiment is overwhelmingly positive, with a consensus price target of $473.89 implying significant upside.
The outlook for UNH is favorable, driven by earnings momentum and strategic initiatives like AI investment. Key risks include regulatory pressures and medical cost trends. The stock presents a compelling opportunity for investors seeking exposure to a leading healthcare company with solid fundamentals and Wall Street support.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Gogoro is a global technology leader in battery-swapping ecosystems for electric two-wheelers. It provides smart, sustainable urban mobility solutions and manages an extensive network of battery stations.
Read more on GGR →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →